Jenburkt Pharmaceuticals Ltd vs Sun Pharmaceutical Industries Limited

A side-by-side comparison of Jenburkt Pharmaceuticals Ltd (JENBURKTPHARMACEUTICALSLTD) and Sun Pharmaceutical Industries Limited (SUNPHARMA) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, Jenburkt Pharmaceuticals Ltd leads JENBURKTPHARMACEUTICALSLTD vs SUNPHARMA on 9 of 14 metrics. See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

  • Valuation40
  • Profitability31
  • Growth11
  • Size & financial health13
ValueReturnsMarginGrowthScaleLow debt

Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.

Valuation

JENBURKTPHARMACEUTICALSLTD takes 4/4

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

14.10
P/E ratio
36.79
2.36
P/B ratio
5.35
1.71%
Dividend yield
0.86%
₹72.64
EPS
₹47.80

Profitability

JENBURKTPHARMACEUTICALSLTD takes 3/4

How efficiently each company turns capital and sales into profit. Higher is better.

20.20%
Return on equity
13.74%
27.00%
Return on capital
17.46%
27.00%
EBITDA margin
30.33%
21.05%
Net margin
19.69%

Growth

Even

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

9.32%
Revenue CAGR (3Y)
10.03%
11.55%
Profit CAGR (3Y)
10.57%

Size & financial health

SUNPHARMA takes 3/4

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹462 Cr
Market cap
₹4.22L Cr
₹152 Cr
Revenue
₹58,462 Cr
₹32 Cr
Net profit
₹11,509 Cr
0.01
Debt / equity
0.06
Jenburkt Pharmaceuticals Ltd
  • + ["Company has reduced debt.", "Company is almost debt free.", "Company has been maintaining a healthy dividend payout of 25.7%"]
  • − ["The company has delivered a poor sales growth of 9.08% over past five years."]
Sun Pharmaceutical Industries Limited
  • + ["Company has delivered good profit growth of 38.3% CAGR over last 5 years", "Company has been maintaining a healthy dividend payout of 33.4%", "Company is almost debt free."]
  • − ["Stock is trading at 5.05 times its book value"]
Jenburkt Pharmaceuticals Ltd full analysis Sun Pharmaceutical Industries Limited full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.